MedTrace Logo

Low-moderate Intensity Pedaling During Immunotherapy Administration

NCT04127318 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2022-09-23

No results posted yet for this study

Summary

The purpose of this study is to determine the feasibility pedaling using an under-the desk bike during immunotherapy infusions. Also, the study hopes to evaluate how pedaling impacts quality of life and treatment response biomarkers. Lastly, the study will evaluate the relationships between treatment response and muscle mass which is evaluated with computerized tomography (CT) scans.

Conditions

  • Cancer of Skin
  • Cancer of Kidney
  • Cancer of Bladder
  • Exercise, Aerobic
  • Immunotherapy

Interventions

BEHAVIORAL

Pedaling Group

Participants will pedal at low-moderate intensity using a stationary pedal ergometer concurrent to their immunotherapy infusion (30 minutes).

Sponsors & Collaborators

  • Rush University Medical Center

    lead OTHER

Principal Investigators

  • Timothy M Kuzel, MD · Rush University Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-31
Primary Completion
2020-10-31
Completion
2020-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04127318 on ClinicalTrials.gov